ATOS
ATOSSA THERAPEUTICS, INC.
Company overview
- Market capitalization
- $19.56M
- Employees
- 16
- Latest publication
- 2026-09-29
About ATOSSA THERAPEUTICS, INC.
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Gross Profit | -4,000USD | -4,000USD | -4,000USD | -4,000USD | -4,000USD | -4,000USD | -4,000USD | -4,000USD |
| Research Development | 4,779,000USD | 6,156,000USD | 5,370,000USD | 5,502,000USD | 4,157,000USD | 3,403,000USD | 3,412,000USD | 3,553,000USD |
| Selling General Administrative | 5,091,000USD | 5,280,000USD | 3,881,000USD | 3,538,000USD | 3,257,000USD | 3,748,000USD | 2,973,000USD | 3,552,000USD |
| Selling And Marketing Expenses | 4,000USD | — | 4,000USD | — | — | — | — | 4,000USD |
| Total Operating Expenses | 9,866,000USD | 11,436,000USD | 9,247,000USD | 9,040,000USD | 7,414,000USD | 7,147,000USD | 6,385,000USD | 7,105,000USD |
| Operating Income | -9,870,000USD | -11,436,000USD | -9,251,000USD | -9,040,000USD | -7,414,000USD | -7,151,000USD | -6,385,000USD | -7,105,000USD |
| Interest Income | 309,000USD | 442,000USD | 570,000USD | 645,000USD | 720,000USD | 837,000USD | 1,001,000USD | 1,073,000USD |
| Net Interest Income | 309,000USD | 442,000USD | 570,000USD | 645,000USD | 720,000USD | 837,000USD | 1,001,000USD | 1,073,000USD |
| Income Before Tax | -9,589,000USD | -10,937,000USD | -8,692,000USD | -8,423,000USD | -6,718,000USD | -6,347,000USD | -7,230,000USD | -6,049,000USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income | -9,589,000USD | -10,937,000USD | -8,692,000USD | -8,423,000USD | -6,718,000USD | -6,347,000USD | -7,230,000USD | -6,049,000USD |
| Net Income From Continuing Ops | -9,589,000USD | -10,937,000USD | -8,692,000USD | -8,423,000USD | -6,718,000USD | -6,347,000USD | -7,230,000USD | -6,049,000USD |
| Ebit | -9,870,000USD | -11,436,000USD | -8,692,000USD | -9,040,000USD | -7,414,000USD | -7,151,000USD | -6,385,000USD | -7,105,000USD |
| Ebitda | -9,866,000USD | -11,432,000USD | -8,688,000USD | -9,036,000USD | -7,410,000USD | -7,147,000USD | -6,381,000USD | -7,101,000USD |
| Depreciation And Amortization | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Reconciled Depreciation | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Total Other Income Expense Net | 281,000USD | 499,000USD | 559,000USD | 617,000USD | 696,000USD | 804,000USD | -845,000USD | 1,056,000USD |
| Income Tax Expense | — | — | — | — | — | — | -7,230,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 16,000USD | 17,000USD | 23,000USD | 8,000USD | 23,000USD | 46,600USD | 52,789USD | 44,197USD |
| Gross Profit | -16,000USD | -17,000USD | -23,000USD | -8,000USD | -23,000USD | -46,600USD | -52,789USD | -44,197USD |
| Research Development | 21,185,000USD | 14,117,000USD | 17,334,000USD | 15,083,000USD | 9,210,000USD | 6,608,000USD | 7,131,967USD | 4,209,981USD |
| Selling General Administrative | 15,956,000USD | 13,504,000USD | 14,043,000USD | 12,608,000USD | 11,311,000USD | 7,999,000USD | 10,620,008USD | 7,224,252USD |
| Total Operating Expenses | 37,141,000USD | 27,621,000USD | 31,377,000USD | 27,691,000USD | 20,521,000USD | 14,607,000USD | 17,265,425USD | 11,434,233USD |
| Operating Income | -37,141,000USD | -27,621,000USD | -31,377,000USD | -27,691,000USD | -20,521,000USD | -14,607,000USD | -17,265,425USD | -11,434,233USD |
| Interest Income | 2,377,000USD | 4,050,000USD | 3,777,000USD | 877,000USD | 6,000USD | — | — | — |
| Net Interest Income | 2,377,000USD | 4,050,000USD | 3,777,000USD | 877,000USD | 6,000USD | -938,794USD | 0USD | — |
| Income Before Tax | -34,770,000USD | -25,504,000USD | -30,094,000USD | -26,960,000USD | -20,606,000USD | -17,828,000USD | -17,239,777USD | -11,404,934USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Net Income | -34,770,000USD | -25,504,000USD | -30,094,000USD | -26,229,000USD | -20,606,000USD | -17,828,000USD | -17,239,777USD | -11,404,934USD |
| Net Income From Continuing Ops | -34,770,000USD | -25,504,000USD | -29,831,000USD | -26,960,000USD | -20,606,000USD | -17,827,952USD | -17,239,777USD | -11,404,934USD |
| Ebit | -37,141,000USD | -27,621,000USD | -31,377,000USD | -27,691,000USD | -20,521,000USD | -14,607,000USD | -17,265,425USD | -11,434,233USD |
| Ebitda | -37,125,000USD | -27,604,000USD | -31,354,000USD | -27,683,000USD | -20,498,000USD | -14,560,000USD | -17,212,636USD | -11,390,036USD |
| Depreciation And Amortization | 16,000USD | 17,000USD | 23,000USD | 8,000USD | 23,000USD | 47,000USD | 52,789USD | 44,197USD |
| Reconciled Depreciation | 16,000USD | 17,000USD | 11,000USD | 8,000USD | 23,000USD | 46,520USD | 52,789USD | 44,197USD |
| Total Other Income Expense Net | 2,371,000USD | 2,117,000USD | 1,283,000USD | 731,000USD | -85,000USD | -3,221,000USD | 25,648USD | 29,299USD |
| Interest Expense | — | — | — | 8,000USD | 85,000USD | 938,794USD | 0USD | 0USD |
| Income Tax Expense | — | — | — | -731,000USD | -213,558USD | 3,271,361USD | -119,071USD | -29,299USD |
| Non Operating Income Net Other | — | — | — | 731,000USD | -85,000USD | -2,281,766USD | 25,648USD | 29,299USD |
| Net Income Applicable To Common Shares | — | — | — | -26,960,000USD | -20,606,000USD | -22,330,751USD | -17,239,777USD | -22,884,242USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 32,281,000USD | 37,943,000USD | 47,608,000USD | 58,012,000USD | 64,515,000USD | 70,747,000USD | 76,444,000USD | 79,477,000USD |
| Cash And Equivalents | 26,094,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 31,010,000USD | 36,668,000USD | 45,618,000USD | 55,678,000USD | 62,517,000USD | 68,744,000USD | 74,457,000USD | 77,111,000USD |
| Other Current Assets | 1,793,000USD | 4,950,000USD | 4,319,000USD | 3,833,000USD | 1,185,000USD | 3,628,000USD | 3,373,000USD | 2,345,000USD |
| Other Non Current Assets | 1,271,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 5,451,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,451,000USD | 7,457,000USD | 8,255,000USD | 8,225,000USD | 6,820,000USD | 5,425,000USD | 4,967,000USD | 5,796,000USD |
| Other Current Liabilities | 1,123,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 26,830,000USD | 30,486,000USD | 39,353,000USD | 49,787,000USD | 57,695,000USD | 65,322,000USD | 71,477,000USD | 73,681,000USD |
| Total Equity Including Noncontrolling Interest | 26,830,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 1,976,000USD | 2,569,000USD | 4,293,000USD | 3,536,000USD | 2,010,000USD | 1,165,000USD | 679,000USD | 1,561,000USD |
| Common Stock | 1,796,000USD | 1,550,000USD | 1,550,000USD | 23,488,000USD | 23,488,000USD | 23,488,000USD | 23,488,000USD | 22,882,000USD |
| Retained Earnings | -264,642,000USD | -256,151,000USD | -246,562,000USD | -235,625,000USD | -226,933,000USD | -218,510,000USD | -211,792,000USD | -205,445,000USD |
| Total Liab | — | 7,457,000USD | 8,255,000USD | 8,225,000USD | 6,820,000USD | 5,425,000USD | 4,967,000USD | 5,796,000USD |
| Other Current Liab | — | 4,888,000USD | 3,962,000USD | 4,689,000USD | 4,810,000USD | 4,260,000USD | 4,288,000USD | 4,235,000USD |
| Capital Stock | — | 1,550,000USD | 1,550,000USD | 23,488,000USD | 23,488,000USD | 23,488,000USD | 23,488,000USD | 22,882,000USD |
| Cash | — | 31,718,000USD | 41,299,000USD | 51,845,000USD | 57,857,000USD | 65,116,000USD | 71,084,000USD | 74,766,000USD |
| Cash And Short Term Investments | — | 31,718,000USD | 41,299,000USD | 51,845,000USD | 57,857,000USD | 65,116,000USD | 71,084,000USD | 74,766,000USD |
| Net Debt | — | -31,718,000USD | -41,299,000USD | -51,845,000USD | -57,857,000USD | -65,116,000USD | -71,084,000USD | -74,766,000USD |
| Common Stock Shares Outstanding | — | 8,622,289shares | 8,611,317shares | 8,611,428shares | 8,611,362shares | 8,611,334shares | 8,441,426shares | 8,384,844shares |
| Non Current Assets Total | — | 1,275,000USD | 1,990,000USD | 2,334,000USD | 1,998,000USD | 2,003,000USD | 1,987,000USD | 2,366,000USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 1,275,000USD | 1,990,000USD | 2,334,000USD | 1,998,000USD | 2,003,000USD | 1,987,000USD | 2,366,000USD |
| Net Working Capital | — | 29,211,000USD | 37,363,000USD | 47,453,000USD | 55,697,000USD | 63,319,000USD | 69,490,000USD | 71,315,000USD |
| Unclassified Equity | — | 283,537,000USD | 282,815,000USD | 238,436,000USD | 237,652,000USD | 236,856,000USD | 236,293,000USD | 233,362,000USD |
| Inventory | — | — | — | — | 3,475,000USD | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | 0USD | — | — | — |
| Long Term Investments | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 47,608,000USD | 76,444,000USD | 96,252,000USD | 123,532,000USD | 141,262,000USD | 42,843,244USD | 14,500,638USD | 11,720,446USD |
| Other Current Assets | 4,319,000USD | 3,373,000USD | 2,272,000USD | 1,317,000USD | 3,791,000USD | 2,471,564USD | 888,474USD | 650,776USD |
| Total Liab | 8,255,000USD | 4,967,000USD | 5,236,000USD | 5,568,000USD | 3,126,000USD | 15,675,312USD | 1,344,633USD | 2,915,436USD |
| Total Stockholder Equity | 39,353,000USD | 71,477,000USD | 91,016,000USD | 117,964,000USD | 138,136,000USD | 27,167,932USD | 13,156,005USD | 8,805,010USD |
| Other Current Liab | 3,962,000USD | 4,288,000USD | 4,430,000USD | 2,603,000USD | 1,409,000USD | 14,046,855USD | 950,829USD | 2,562,108USD |
| Common Stock | 1,550,000USD | 23,488,000USD | 22,792,000USD | 22,792,000USD | 22,792,000USD | 8,558,778USD | 1,643,565USD | 1,052,372USD |
| Capital Stock | 1,550,000USD | 23,488,000USD | 22,792,000USD | 22,792,000USD | 22,792,000USD | 8,558,779USD | 1,643,566USD | 1,052,374USD |
| Retained Earnings | -246,562,000USD | -211,792,000USD | -186,288,000USD | -156,194,000USD | -129,234,000USD | -111,898,992USD | -94,071,040USD | -76,831,263USD |
| Cash | 41,299,000USD | 71,084,000USD | 88,460,000USD | 110,890,000USD | 136,377,000USD | 39,663,671USD | 12,691,136USD | 10,380,493USD |
| Cash And Short Term Investments | 41,299,000USD | 71,084,000USD | 88,460,000USD | 110,890,000USD | 136,377,000USD | 39,663,671USD | 12,691,136USD | 10,380,493USD |
| Total Current Assets | 45,618,000USD | 74,457,000USD | 92,219,000USD | 118,197,000USD | 141,240,000USD | 42,770,175USD | 14,319,266USD | 11,549,366USD |
| Total Current Liabilities | 8,255,000USD | 4,967,000USD | 5,236,000USD | 5,568,000USD | 3,126,000USD | 15,671,521USD | 1,322,742USD | 2,915,436USD |
| Net Debt | -41,299,000USD | -71,084,000USD | -88,460,000USD | -110,890,000USD | -136,377,000USD | -39,645,618USD | -12,640,657USD | -10,380,493USD |
| Accounts Payable | 4,293,000USD | 679,000USD | 806,000USD | 2,965,000USD | 1,717,000USD | 1,588,613USD | 293,171USD | 353,328USD |
| Common Stock Shares Outstanding | 8,611,321shares | 8,390,618shares | 8,405,400shares | 8,441,600shares | 7,796,667shares | 753,902shares | 566,464shares | 277,183shares |
| Non Current Assets Total | 1,990,000USD | 1,987,000USD | 4,033,000USD | 5,335,000USD | 22,000USD | 73,068USD | 181,371USD | 171,080USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 1,000USD | 1,000USD | 3,790USD | 21,890USD | 353,328USD |
| Non Currrent Assets Other | 1,990,000USD | 1,987,000USD | 2,323,000USD | 635,000USD | 2,000USD | 17,217USD | 17,217USD | 17,218USD |
| Net Working Capital | 37,363,000USD | 69,490,000USD | 86,983,000USD | 112,629,000USD | 138,114,000USD | 27,098,654USD | 12,996,524USD | 8,633,930USD |
| Unclassified Equity | 282,815,000USD | 236,293,000USD | 231,720,000USD | 228,574,000USD | 222,368,000USD | 121,949,367USD | 103,939,914USD | 83,531,527USD |
| Long Term Investments | — | 0USD | 1,710,000USD | 4,700,000USD | 0USD | — | — | — |
| Net Receivables | — | — | -1,425,000USD | 743,000USD | 1,072,000USD | 634,940USD | 739,656USD | 518,097USD |
| Inventory | — | — | 1,487,000USD | 5,247,000USD | 2,598,000USD | 1,923,902USD | 972,344USD | 619,833USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD | -582,000USD | — | 0USD | — |
| Other Assets | — | — | — | 635,000USD | 2,000USD | 0USD | 350USD | 17,218USD |
| Net Tangible Assets | — | — | — | 117,964,000USD | 137,554,000USD | 26,533,557USD | 13,156,004USD | 8,705,633USD |
| Property Plant Equipment Net | — | — | — | — | 20,000USD | 38,685USD | 84,829USD | 54,487USD |
| Property Plant Equipment Gross | — | — | — | — | 36,000USD | 20,632USD | 84,479USD | 54,487USD |
| Unclassified Current Assets | — | — | — | — | -2,598,000USD | -1,923,902USD | — | — |
| Intangible Assets | — | — | — | — | — | 13,375USD | 68,542USD | 99,375USD |
| Current Deferred Revenue | — | — | — | — | — | 1,057,032USD | 977,308USD | — |
| Short Term Debt | — | — | — | — | — | 36,053USD | 78,742USD | — |
| Short Long Term Debt Total | — | — | — | — | — | 18,053USD | 50,479USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | -1,057,032USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -9,589,000USD | -10,937,000USD | -8,692,000USD | -8,423,000USD | -6,718,000USD | -6,347,000USD | -7,230,000USD | -6,049,000USD |
| Depreciation | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Stock Based Compensation | 722,000USD | 503,000USD | 784,000USD | 796,000USD | 563,000USD | 774,000USD | 749,000USD | 352,000USD |
| Other Non Cash Items | 722,000USD | -301,000USD | 784,000USD | 845,000USD | — | 4,000USD | 1,709,000USD | 2,000USD |
| Change In Working Capital | -718,000USD | -109,000USD | 1,899,000USD | 364,000USD | 192,000USD | -1,486,000USD | 18,000USD | 1,160,000USD |
| Total Cash From Operating Activities | -9,581,000USD | -10,539,000USD | -6,005,000USD | -7,259,000USD | -5,959,000USD | -7,051,000USD | -4,750,000USD | -4,531,000USD |
| Capital Expenditures | 0USD | -7,000USD | -7,000USD | 0USD | -9,000USD | 0USD | -10,000USD | -3,000USD |
| Free Cash Flow | -9,581,000USD | -10,546,000USD | -6,012,000USD | -7,259,000USD | -5,968,000USD | -7,051,000USD | -4,760,000USD | -4,534,000USD |
| Change In Cash | -9,581,000USD | -10,546,000USD | -6,012,000USD | -7,259,000USD | -5,968,000USD | -3,682,000USD | -4,760,000USD | -4,434,000USD |
| Begin Period Cash Flow | 41,409,000USD | 51,955,000USD | 57,967,000USD | 65,226,000USD | 71,194,000USD | 74,876,000USD | 79,636,000USD | 84,070,000USD |
| End Period Cash Flow | 31,828,000USD | 41,409,000USD | 51,955,000USD | 57,967,000USD | 65,226,000USD | 71,194,000USD | 74,876,000USD | 79,636,000USD |
| Total Cashflows From Investing Activities | — | -7,000USD | -7,000USD | — | -9,000USD | — | -10,000USD | -3,000USD |
| Total Cash From Financing Activities | — | 0USD | 0USD | 0USD | 0USD | 3,369,000USD | 0USD | 100,000USD |
| Investments | — | — | -7,000USD | 0USD | -9,000USD | 0USD | -10,000USD | -3,000USD |
| Change To Inventory | — | — | — | -1,396,000USD | 19,000USD | — | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | 0USD | — | — |
| Other Cashflows From Financing Activities | — | — | — | — | — | 3,369,000USD | -273,000USD | 100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -34,770,000USD | -25,504,000USD | -30,094,000USD | -26,960,000USD | -20,606,000USD | -17,827,952USD | -17,239,777USD | -11,404,934USD |
| Depreciation | 16,000USD | 17,000USD | 23,000USD | 8,000USD | 23,000USD | 46,520USD | 52,789USD | 44,197USD |
| Stock Based Compensation | 2,646,000USD | 2,292,000USD | 4,621,000USD | 6,788,000USD | 5,267,000USD | 3,019,409USD | 8,844,037USD | 2,463,521USD |
| Other Non Cash Items | 2,346,000USD | 1,717,000USD | 2,990,000USD | 3,000USD | 5,622,000USD | 938,794USD | 5,806USD | 2,693,309USD |
| Change To Inventory | -983,000USD | -611,000USD | 2,544,000USD | -329,000USD | 437,000USD | -104,716USD | 221,558USD | — |
| Change In Working Capital | 2,346,000USD | 448,000USD | 1,519,000USD | -599,000USD | -1,156,000USD | -111,352USD | -791,297USD | -64,405USD |
| Total Cash From Operating Activities | -29,762,000USD | -21,030,000USD | -20,941,000USD | -20,760,000USD | -16,472,000USD | -11,570,282USD | -9,128,442USD | -8,961,621USD |
| Capital Expenditures | -23,000USD | -19,000USD | -14,000USD | -27,000USD | -9,000USD | -9,367USD | -7,628USD | -110,906USD |
| Free Cash Flow | -29,785,000USD | -21,049,000USD | -20,955,000USD | -20,787,000USD | -16,481,000USD | -11,579,649USD | -9,136,070USD | -9,072,527USD |
| Total Cashflows From Investing Activities | -23,000USD | -19,000USD | -14,000USD | -4,727,000USD | -9,000USD | -9,367USD | -7,625USD | -110,906USD |
| Total Cash From Financing Activities | 0USD | 3,673,000USD | -1,475,000USD | 1,000USD | 113,304,000USD | 38,552,184USD | 11,336,710USD | 12,290,551USD |
| Change In Cash | -29,785,000USD | -17,376,000USD | -22,430,000USD | -25,487,000USD | 96,823,000USD | 26,972,535USD | 2,200,643USD | 3,218,024USD |
| Begin Period Cash Flow | 71,194,000USD | 88,570,000USD | 111,000,000USD | 136,487,000USD | 39,664,000USD | 12,691,136USD | 10,490,493USD | 7,272,469USD |
| End Period Cash Flow | 41,409,000USD | 71,194,000USD | 88,570,000USD | 111,000,000USD | 136,487,000USD | 39,663,671USD | 12,691,136USD | 10,490,493USD |
| Unclassified Operating Cash Flow | -2,346,000USD | — | — | — | -5,622,000USD | 2,364,299USD | — | -2,693,309USD |
| Investments | — | -19,000USD | -2,022,000USD | -4,727,000USD | -9,000USD | -9,367USD | -7,625USD | -110,906USD |
| Sale Purchase Of Stock | — | 0USD | -1,475,000USD | 0USD | -573USD | 9,612,166USD | 11,336,710USD | 12,290,551USD |
| Other Cashflows From Financing Activities | — | 3,673,000USD | -1,473,525USD | -4,727,000USD | 43,636,000USD | 9,435,596USD | 11,336,710USD | 12,290,551USD |
| Change To Account Receivables | — | — | 743,000USD | 329,000USD | -437,000USD | 104,716USD | -221,558USD | -159,821USD |
| Other Cashflows From Investing Activities | — | — | -13,986USD | -4,700USD | -9,000USD | -9,367USD | -7,625USD | -110,906USD |
| Unclassified Investing Cash Flow | — | — | 2,035,986USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | 1,473,525USD | 4,728,000USD | 69,668,573USD | 24,007,221USD | -11,336,710USD | -12,290,551USD |
| Change To Liabilities | — | — | — | 2,442,000USD | 128,000USD | 1,295,442USD | -222,040USD | 280,004USD |
| Issuance Of Capital Stock | — | — | — | 0USD | 69,668,000USD | 38,566,606USD | 347,627USD | 12,290,551USD |
| Cash And Cash Equivalents Changes | — | — | — | -25,487,000USD | 96,823,000USD | 26,972,535USD | 2,200,643USD | 3,218,024USD |
| Dividends Paid | — | — | — | — | — | -4,502,799USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.